Skip to content
OpenCapital
Get started

Harmony Biosciences Holdings, Inc. HRMY Free cash flow yield

Free cash flow yield at other companies

Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
10.9%-9.2pp
Alkermes logo
AlkermesALKS
3.8%-5.2pp
Axsome Therapeutics logo
Axsome TherapeuticsAXSM
-0.8%-0.3pp
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
19.2%+13.6pp
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
6.1%-3.5pp
Acadia Pharmaceuticals logo
Acadia PharmaceuticalsACAD
5.5%—

Other financials

Income statement

See full
Revenue$215.4M+16.6%
Gross profit$170.9M+11.9%
Operating income$37.3M-33.7%
Net income$32.5M-28.7%
EPS (diluted)$0.55-29.5%

Balance sheet

See full
Cash & equivalents$589.4M+20.5%
Total debt$164.6M-7.2%
Total equity$910.3M+26.3%
Total assets$1.3B+20.5%

Cash flow

See full
Operating cash flow$27.8M-18.3%
CapEx$107.0K-79.1%
Free cash flow$126.0M+67.9%

Valuation

See full
Market cap$1.98B-14.9%
Enterprise value$1.55B-24.9%
P/E13.6×-1.6×
P/S2.2×-0.9×

Profitability

See full
Gross margin76.5%-1.8pp
Operating margin21.1%-5.1pp
Net margin16.2%-4.3pp
FCF margin40.1%+9.5pp

Returns & leverage

See full
Return on equity17.9%-6.9pp
Debt / equity0.2×-0.1×
Current ratio3.6×-0.1×

Where this comes from

Calculated from Harmony Biosciences Holdings, Inc.’s reported figures.

free cash flow/market cap=16.1%

Based on trailing twelve months.

The official record: Harmony Biosciences Holdings, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Harmony Biosciences Holdings, Inc.'s free cash flow yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Harmony Biosciences Holdings, Inc.'s free cash flow yield?
Harmony Biosciences Holdings, Inc. (HRMY) reported free cash flow yield of 16.1% in Q4 2025.
How has Harmony Biosciences Holdings, Inc.'s free cash flow yield changed year-over-year?
Harmony Biosciences Holdings, Inc.'s free cash flow yield increased by 44.9% year-over-year, from 11.1% to 16.1%.
What is the long-term trend for Harmony Biosciences Holdings, Inc.'s free cash flow yield?
Over 4 years (2020 to 2025), Harmony Biosciences Holdings, Inc.'s free cash flow yield has grown at a 224.7% compound annual growth rate (CAGR), from -0.1% to 16.1%.
What does free cash flow yield mean?
Trailing-twelve-month free cash flow divided by market capitalization at the quarter end. The cash return the business generates relative to its market price.